Hexapeptide-2

Hexapeptide-2

Hexapeptide-2

Hexapeptide-2, or more commonly referred to as GHRP-6, is an α-melanocyte-stimulating hormone antagonist.

 

 

СКУ: 198839 Категорија:
Поделите своју љубав

Hexapeptide-2, or more commonly referred to as GHRP-6, is an α-melanocyte-stimulating hormone antagonist. Inhibiting tyrosinase активност, it suppresses both the production and subsequent deposition of pigment; improving overall skin tone is one of its primary effects.

The incorporation of D-amino acids within its structure significantly enhances metabolic stability, along with strengthened receptor binding stability and affinity. Structurally similar to α-MSH itself, Hexapeptide-2 blocks this hormone’s ability to bind to its рецептори – melanocyte activity being the direct target inhibited.

As an equivalent of GHRP-6, pulsatile pituitary secretion of growth hormone is stimulated; protein synthesis, bone development (and all related repair processes), зарастање рана, and enhancement of immune function are all positively influenced.

Секуенце

His-Trp-Ala-Trp-Phe-Lys or H-His-D-Trp-Ala-Trp-D-Phe-Lys-NH2

ЦАС број

87616-84-0

Молецулар Формула

C46H56N12O6

Молецулар Веигхт

873.014

Hexapeptide-2 Related Research

1.Potential Therapeutic Applications

Promising cosmetological potential exists as a whitening agent or a therapeutic for various forms of hyperpigmentation disorders. The antagonistic properties also suggest broader potential uses: appetite stimulation, кахексија improvement, and modulation of inflammation.

2.Antagonizing the α-MSH signaling pathway

Competitive receptor binding is the key mechanism; reducing меланин synthesis is the direct outcome.

Effective skin lightening is the end result of this process. Appetite centers in the хипоталамус may be influenced, with quality of life improvements for patients with cachexia or age-related loss of appetite being a valuable secondary benefit.

3.Promoting Pulsatile Growth Hormone Secretion

Synergistic enhancement of endogenous ghrelin and suppression of somatostatin are what drive the desired pulsatile release.

This physiological pattern of release is considered a more effective therapeutic approach to avoid desensitization.

4.Stimulating Tissue and Bone Repair

Increased levels of growth hormone and IGF-1 promote mitotic and anabolic активност, thereby stimulating tissue proliferation, диференцијације, and repair.

This accelerates the repair of soft tissue and bone, promotes фибробласт proliferation and колаген синтеза, and enhances wound healing.

Additionally, it stimulates osteoblast activity and bone matrix formation, which helps increase bone density, accelerate fracture healing, and combat age-related bone loss.

ЦОА

ХПЛЦ

МС

(1) Цхен, Д.; Ли, Ј.; Пан, Т.; Ву, Р.; Тао, И.; Лин, Х. Антибиофилмска активност широког спектра хексапептида који формирају амилоид. Мицробиал Биотецхнологи 2020, 14 (2), 656-667. ДОИ: 10.1111/1751-7915.13721.

(2) Домет, А. М.; ВандерЗанден, Ц. М.; Мајевска, П. В.; Мајевски, Ј.; Цхи, Е. И. Фибрилација посредована мембраном и токсичност тау хексапептида ПХФ6. Јоурнал оф Биологицал Цхемистри 2019, 294 (42), 15304-15317. ДОИ: 10.1074/јбц.РА119.010003.

(3) Хуанг, И.; Ванг, Т.; Цхен, И.; Лин, Х.; Цхен, Д. Амилоид хексапептид спречава зубни каријес стварањем антибиофилма. Јоурнал оф Дентистри 2023, 135. ДОИ: 10.1016/ј.јдент.2023.104596.

(4) Мохамед, Т.; Гујрал, С. С.; Рао, П. П. Н. Хексапептид из тауа АцПХФ6 промовише бета-амилоид (Аβ) Фибрилогенеза. АЦС Цхемицал Неуросциенце 2017, 9 (4), 773-782. ДОИ: 10.1021/ацсцхемнеуро.7б00433.

(5) Совмиа, К.; Бхат, М. И.; Бајај, Р.; Капила, С.; Капила, Р. Антиоксидативни и антиинфламаторни потенцијал са трансепителним транспортом хексапептида добијеног од бивољег казеина (ИФИПКЛ). Фоод Биосциенце 2019, 28, 151-163. ДОИ: 10.1016/ј.фбио.2019.02.003.

Секуенце:

His-Trp-Ala-Trp-Phe-Lys or H-His-D-Trp-Ala-Trp-D-Phe-Lys-NH2

ЦАС:

87616-84-0

М.В:

873.014 г/мол

Хоме Тражи Вхатсапп Услуге Производ